Good day, and welcome to the I-Mab Business Update Call. [Operator Instructions]. As a reminder, this conference call is being recorded and will be available for replay on the company's website. I ...
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...
Less than two years after laying out plans to divest its China operations and become a U.S.-focused biotech, I-Mab Biopharma is re-staking its claim in the Asia-Pacific region. The drugmaker mapped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results